tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

COYA Stock Latest News

COYA-302: De-Risked Treg Platform With Compelling FTD Data and ALS Phase 2 Catalyst Supporting Buy Rating
RatingsCOYA-302: De-Risked Treg Platform With Compelling FTD Data and ALS Phase 2 Catalyst Supporting Buy Rating
2d ago
COYA
Coya Therapeutics: Early COYA 302 Validation, Regulatory De-Risking, and Upcoming Catalysts Support Buy Rating
PremiumRatings
Coya Therapeutics: Early COYA 302 Validation, Regulatory De-Risking, and Upcoming Catalysts Support Buy Rating
3d ago
COYA
Coya Therapeutics Reports Positive Frontotemporal Dementia Study Data
PremiumCompany Announcements
Coya Therapeutics Reports Positive Frontotemporal Dementia Study Data
3d ago
8K
COYA
Coya Therapeutics announces FDA acceptance of COYA 302 IND application
PremiumThe Fly
Coya Therapeutics announces FDA acceptance of COYA 302 IND application
6d ago
COYA
Coya Therapeutics: Clinical Momentum, Extended Cash Runway, and DCF-Derived Upside Support Reiterated Buy and $18 Target
PremiumRatings
Coya Therapeutics: Clinical Momentum, Extended Cash Runway, and DCF-Derived Upside Support Reiterated Buy and $18 Target
6d ago
COYA
Coya announces Health Canada acceptance of COYA 302 clinical trial application
PremiumThe FlyCoya announces Health Canada acceptance of COYA 302 clinical trial application
19d ago
COYA
Coya Therapeutics Receives $4.2M Milestone Payment
Premium
Company Announcements
Coya Therapeutics Receives $4.2M Milestone Payment
25d ago
8K
COYA
Buy Rating for Coya: Phase 2 Trial Initiation and Financial Milestones Boost Prospects
Premium
Ratings
Buy Rating for Coya: Phase 2 Trial Initiation and Financial Milestones Boost Prospects
1M ago
COYA
Coya Therapeutics, Inc.: Promising Advancements in ALS and FTD Treatment with COYA-302
PremiumRatings
Coya Therapeutics, Inc.: Promising Advancements in ALS and FTD Treatment with COYA-302
1M ago
COYA
Coya Therapeutics commences dosing in ALSTARS trial
PremiumThe Fly
Coya Therapeutics commences dosing in ALSTARS trial
1M ago
COYA
Coya Therapeutics: Strong Financial Position and Upcoming Catalysts Support Buy Rating
PremiumRatings
Coya Therapeutics: Strong Financial Position and Upcoming Catalysts Support Buy Rating
2M ago
COYA
Coya Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
Coya Therapeutics Reports Q3 2025 Financial Results
2M ago
8K
COYA
Coya Therapeutics reports Q3 EPS (13c), consensus (30c)
PremiumThe FlyCoya Therapeutics reports Q3 EPS (13c), consensus (30c)
2M ago
COYA
Coya Therapeutics price target raised to $17 from $16 at Lake Street
Premium
The Fly
Coya Therapeutics price target raised to $17 from $16 at Lake Street
2M ago
COYA
Coya Therapeutics announces results from COYA 303 in vivo animal study
Premium
The Fly
Coya Therapeutics announces results from COYA 303 in vivo animal study
2M ago
COYA
Coya Therapeutics’ Promising ALS Study: A Potential Game-Changer?
PremiumCompany Announcements
Coya Therapeutics’ Promising ALS Study: A Potential Game-Changer?
3M ago
COYA
Coya Therapeutics Announces Public Offering of Shares
PremiumCompany Announcements
Coya Therapeutics Announces Public Offering of Shares
3M ago
8K
COYA
Coya Therapeutics 3.64M Spot Secondary priced at $5.50
PremiumThe Fly
Coya Therapeutics 3.64M Spot Secondary priced at $5.50
3M ago
COYA
Coya Therapeutics announces common stock offering, no amount given
PremiumThe Fly
Coya Therapeutics announces common stock offering, no amount given
3M ago
COYA
Positive Outlook for Coya Therapeutics Driven by Promising COYA-302 Clinical Developments and Regulatory Support
PremiumRatingsPositive Outlook for Coya Therapeutics Driven by Promising COYA-302 Clinical Developments and Regulatory Support
3M ago
COYA
Coya Therapeutics completes enrollment in IL-2 and CTLA4-Ig study
Premium
The Fly
Coya Therapeutics completes enrollment in IL-2 and CTLA4-Ig study
3M ago
COYA
Promising Outlook for COYA 302 Amidst Phase 2 Trial and Near-Term Catalysts Justifies Buy Rating
Premium
Ratings
Promising Outlook for COYA 302 Amidst Phase 2 Trial and Near-Term Catalysts Justifies Buy Rating
4M ago
COYA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >